The activities of lignans and neolignans which directly or indirectly
affect the cardiovascular system are reviewed. The results from molecu
lar screening methods and animal models are included and an attempt to
identify the molecular features which might influence some of the act
ivities is made. The question of the benefit of low levels of circulat
ing lignans in an organism is considered.